COVID-19 presenting with ophthalmoparesis from cranial nerve palsy

• Published in: Neurology Vol. 95; no. 5; pp. 221 - 223
• Main Authors: Dinkin, Marc, Gao, Virginia, Kahan, Joshua, Bobker, Sarah, Simonetto, Marialaura, Wechsler, Paul, Harpe, Jasmin, Greer, Christine, Mints, Gregory, Salama, Gayle, Tsiouris, Apostolos John, Leifer, Dana
• Format: Journal Article
• Language: English
• Published: United States American Academy of Neurology 04-08-2020
• Subjects: Adult; Aged; Betacoronavirus; Coronavirus Infections - complications; Coronavirus Infections - diagnosis; Coronavirus Infections - drug therapy; Coronavirus Infections - physiopathology; COVID-19; Diplopia - diagnostic imaging; Diplopia - etiology; Diplopia - physiopathology; Enzyme Inhibitors - therapeutic use; Female; Humans; Hydroxychloroquine - therapeutic use; Immunoglobulins, Intravenous - therapeutic use; Immunologic Factors - therapeutic use; Magnetic Resonance Imaging; Male; Miller Fisher Syndrome - diagnostic imaging; Miller Fisher Syndrome - etiology; Miller Fisher Syndrome - physiopathology; Miller Fisher Syndrome - therapy; Oculomotor Nerve - diagnostic imaging; Ophthalmoplegia - diagnostic imaging; Ophthalmoplegia - etiology; Ophthalmoplegia - physiopathology; Optic Nerve - diagnostic imaging; Pandemics; Pneumonia, Viral - complications; Pneumonia, Viral - diagnosis; Pneumonia, Viral - drug therapy; Pneumonia, Viral - physiopathology; SARS-CoV-2
• ISSN: 0028-3878; 1526-632X
• DOI: 10.1212/WNL.0000000000009700

Neurological complications of COVID-19 are not well described. We report two patients who were diagnosed with COVID-19 after presenting with diplopia and ophthalmoparesis.